3-Acetylpyridine-Adenine Dinucleotide structure
|
Common Name | 3-Acetylpyridine-Adenine Dinucleotide | ||
---|---|---|---|---|
CAS Number | 102029-93-6 | Molecular Weight | 708.42 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H28N6Na2O14P2 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of 3-Acetylpyridine-Adenine Dinucleotide3-Acetylpyridine adenine dinucleotide (disodium) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | Adenosine 5'-(trihydrogen diphosphate), P'→5'-ester with 1-(1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinyl)ethanone, disodium salt (9CI) |
---|
Description | 3-Acetylpyridine adenine dinucleotide (disodium) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Molecular Formula | C22H28N6Na2O14P2 |
---|---|
Molecular Weight | 708.42 |
Exact Mass | 662.113892 |
PSA | 311.22000 |
LogP | -7.96 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
RIDADR | NONH for all modes of transport |
Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination.
Malaria Journal 14 , 213, (2015) The discovery of malaria transmission-blocking compounds is seen as key to malaria elimination strategies and gametocyte-screening platforms are critical filters to identify active molecules. However,... |
|
A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs.
J. Antimicrob. Chemother. 70 , 1357-66, (2015) The development of drugs to reduce malaria transmission is an important part of malaria eradication plans. We set out to develop and validate a combination of new screening assays for prioritization o... |